technetium tc 99m dimercaptosuccinic acid has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, K; Hamanaka, D; Iida, Y; Ikekubo, K; Konishi, J; Makimoto, K; Mori, T; Ohta, H; Shimazu, A; Yamamoto, K | 1 |
| Andócs, G; Balogh, L; Jánoki, GA; Láng, J; Perge, E; Thuróczy, J; Vajdovich, P | 1 |
2 other study(ies) available for technetium tc 99m dimercaptosuccinic acid and Lymphoma
| Article | Year |
|---|---|
A new imaging agent for medullary carcinoma of the thyroid.
Topics: Adenocarcinoma; Adult; Calcitonin; Carcinoma; Diagnosis, Differential; Female; Humans; Lymphoma; Male; Middle Aged; Radionuclide Imaging; Succimer; Sulfhydryl Compounds; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms | 1984 |
Oncological scintigraphy in dogs with 99mTechnetium MIBI and DMSA(V)--two case reports.
Topics: Animals; Dog Diseases; Dogs; Female; Head and Neck Neoplasms; Lymphoma; Male; Neurilemmoma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi | 2001 |